Funguria in Hospitalized Patients

Status Completed

Clinical Trial Summary

The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.

Clinical Trial Description

This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative risks for obtaining candiduria. In addition, it will look at identifying subgroups of patients with funguria at high risk for candidemia and identifying subgroups of patients with funguria at high risk for death. Finally, it will attempt to determine if funguria independently predicts fungemia or death. Data will be complemented by surveillance of a comparable population without funguria. ;

Study Design

Related Conditions & MeSH terms

Candidiasis

Clinical Trial Details

NCT number	NCT00138502
Study type	Observational
Source	National Institute of Allergy and Infectious Diseases (NIAID)
Contact
Status	Completed
Phase
Start date	September 17, 2001
Completion date	December 8, 2008

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01982071` - A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia	Phase 4
Completed	`NCT02391532` - Effect of Probiotic Bacteria on Oral Candida in Frail Elderly	N/A
Completed	`NCT01447407` - Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine	Phase 1
Not yet recruiting	`NCT00889356` - Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis	Phase 3
Completed	`NCT00105144` - Study of Micafungin in Patients With Invasive Candidiasis or Candidemia	Phase 3
Completed	`NCT00163111` - A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.	Phase 3
Not yet recruiting	`NCT04502277` - Bioavailability of Flucanazole	Early Phase 1
Completed	`NCT03203551` - Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.	N/A
Completed	`NCT05044156` - Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
Completed	`NCT01322698` - Staging Candidiasis in ICU Patients	N/A
Terminated	`NCT01092832` - A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients	Phase 3
Terminated	`NCT00095316` - Caspofungin Study for Fungal Infections in Adults in Critical Care Settings	Phase 3
Completed	`NCT04122560` - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration	Phase 4
Completed	`NCT02641717` - Validity of Patient-Collected Wet Mounts	N/A
Recruiting	`NCT01253954` - A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China	N/A
Completed	`NCT00797420` - Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers	Phase 1
Completed	`NCT00734539` - Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight	Phase 3
Completed	`NCT00001937` - Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients	Phase 3
Completed	`NCT02666716` - Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients
Terminated	`NCT00692783` - Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility	N/A